<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table2" position="float"><object-id pub-id-type="doi">10.7554/eLife.47163.021</object-id><label>Table 2.</label><caption><title>Clinical signs inNdufs4-LS patients, Ndufs4KO mice and conditional Vglut2:Ndufs4cKO and Gad2:Ndufs4cKO mice.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top"/><th valign="top"><italic>Ndufs4</italic>-LS patients</th><th valign="top">Ndufs4KO mouse</th><th valign="top">Vglut2:Ndufs4cKO mouse<sup>*</sup></th><th valign="top">Gad2:Ndufs4cKO mouse<sup>*</sup></th></tr></thead><tbody><tr><td valign="top"><italic>Decreased lifespan</italic></td><td valign="top">22/22</td><td valign="top">Yes</td><td valign="top">Yes</td><td valign="top">Yes</td></tr><tr><td valign="top"><italic>Feeding impairment</italic></td><td valign="top">8/22</td><td valign="top">n.d</td><td valign="top">Yes</td><td valign="top">Yes</td></tr><tr><td valign="top"><italic>Reduced body weight</italic></td><td valign="top">n.a.</td><td valign="top">Yes</td><td valign="top">Yes</td><td valign="top">Yes</td></tr><tr><td valign="top"><italic>Brainstem lesions</italic></td><td valign="top">14/22</td><td valign="top">Yes</td><td valign="top">Yes</td><td valign="top">No</td></tr><tr><td valign="top"><italic>Basal ganglia lesions</italic></td><td valign="top">9/22</td><td valign="top">Yes</td><td valign="top">No</td><td valign="top">Yes</td></tr><tr><td valign="top"><italic>Ataxia, motor alterations</italic></td><td valign="top">22/22</td><td valign="top">Yes</td><td valign="top">Yes</td><td valign="top">No</td></tr><tr><td valign="top"><italic>Growth retardation</italic></td><td valign="top">11/22</td><td valign="top">Yes</td><td valign="top">Yes</td><td valign="top">Yes</td></tr><tr><td valign="top"><italic>Hypotonia</italic></td><td valign="top">22/22</td><td valign="top">Yes</td><td valign="top">Yes</td><td valign="top">No</td></tr><tr><td valign="top"><italic>Respiratory abnormalities</italic></td><td valign="top">22/22</td><td valign="top">Yes</td><td valign="top">Yes</td><td valign="top">No</td></tr><tr><td valign="top"><italic>Increased sensitivity to VAs</italic></td><td valign="top">n.a.</td><td valign="top">Yes</td><td valign="top">Yes&#8224;</td><td valign="top">No&#8224;</td></tr><tr><td valign="top"><italic>Seizures</italic></td><td valign="top">4/22</td><td valign="top">Yes</td><td valign="top">No</td><td valign="top">Yes</td></tr><tr><td valign="top"><italic>Hypothermia</italic></td><td valign="top">n.a.</td><td valign="top">Yes</td><td valign="top">Yes&#8225;</td><td valign="top">Yes</td></tr></tbody></table><table-wrap-foot><fn><p>n.d, not determined; n.a, not available.&#160;*Reported in this study. &#8224;Reported in <xref ref-type="bibr" rid="bib70">Zimin et al. (2016)</xref>. &#8225;Only in late-stage mice. VAs: volatile anesthetics. Adapted from <xref ref-type="bibr" rid="bib50">Quintana et al. (2012)</xref>.</p></fn></table-wrap-foot></table-wrap>